Share. Connect. Create. Grow. · Socialiya
AstraZeneca stock falls after FDA panel votes against new cancer drug

An advisory panel for the U.S. Food and Drug Administration voted 6-3 against AstraZeneca's oral dru...

BUSINESS NEWS May 01, 2026

AstraZeneca stock falls after FDA panel votes against new cancer drug

An advisory panel for the U.S. Food and Drug Administration voted 6-3 against AstraZeneca's oral drug camizestrant intended for a type of breast cancer...

13 views 0 likes 0 comments
Share:
An advisory panel for the U.S. Food and Drug Administration voted 6-3 against AstraZeneca's oral drug camizestrant intended for a type of breast cancer...

Related News

Latest News

Advertisement

Top Categories

Advertisement
Advertisement
Advertisement
Advertisement